Evidence map›Paper›PMID 31286976›Full record

ArticleJournal of nanobiotechnology2019

Susceptibility of microbial cells to the modified PIP

Robert Bucki, Katarzyna Niemirowicz-Laskowska, Piotr Deptuła, Agnieszka Z Wilczewska, Paweł Misiak, Bonita Durnaś, Krzysztof Fiedoruk, Ewelina Piktel, Joanna Mystkowska, Paul A Janmey

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Interfacial Interactions betweenThe journal of physical chemistry. B · 2026
    Article
  2. Investigating the Effectiveness of Ceragenins againstInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review of PIP2 in Cellular Signaling, Functions and Diseases.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Journal of fungi (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Robert BuckiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Białystok, Poland. buckirobert@gmail.com.
Katarzyna Niemirowicz-LaskowskaDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Białystok, Poland.
Piotr DeptułaDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Białystok, Poland.
Agnieszka Z WilczewskaInstitute of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245, Białystok, Poland.
Paweł MisiakInstitute of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245, Białystok, Poland.
Bonita DurnaśDepartment of Microbiology and Immunology, The Faculty of Medicine and Health Sciences of the Jan Kochanowski University in Kielce, Aleja IX Wieków Kielc, 25-317, Kielce, Poland.
Krzysztof FiedorukDepartment of Microbiology, Medical University of Bialystok, 15-222, Białystok, Poland.
Ewelina PiktelDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Białystok, Poland.
Joanna MystkowskaDepartment of Materials Engineering and Production, Faculty of Mechanical Engineering, Bialystok University of Technology, Wiejska 45C, 15-351, Białystok, Poland.
Paul A JanmeyDepartment of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA.
Medical University of Białystok · PLUniversity of Białystok · PLBialystok University of Technology · PLJan Kochanowski University · PLUniversity of Pennsylvania · US

Funding

Spatial control of actin assembly by phosphoinositidesR01GM111942 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI JANMEY, PAUL A · 2015 to 2018
$1.8M
NIGMS NIH HHS R01 GM111942
6 · The paper itself

Abstract

backgroundMagnetic nanoparticles (MNPs) are characterized by unique physicochemical and biological properties that allow their employment as highly biocompatible drug carriers. Gelsolin (GSN) is a multifunctional actin-binding protein involved in cytoskeleton remodeling and free circulating actin sequestering. It was reported that a gelsolin derived phosphoinositide binding domain GSN 160-169, (PBP10 peptide) coupled with rhodamine B, exerts strong bactericidal activity.

resultsIn this study, we synthesized a new antibacterial and antifungal nanosystem composed of MNPs and a PBP10 peptide attached to the surface. The physicochemical properties of these nanosystems were analyzed by spectroscopy, calorimetry, electron microscopy, and X-ray studies. Using luminescence based techniques and a standard killing assay against representative strains of Gram-positive (Staphylococcus aureus MRSA Xen 30) and Gram-negative (Pseudomonas aeruginosa Xen 5) bacteria and against fungal cells (Candida spp.) we demonstrated that magnetic nanoparticles significantly enhance the effect of PBP10 peptides through a membrane-based mode of action, involving attachment and interaction with cell wall components, disruption of microbial membrane and increased uptake of peptide. Our results also indicate that treatment of both planktonic and biofilm forms of pathogens by PBP10-based nanosystems is more effective than therapy with either of these agents alone.

conclusionsThe results show that magnetic nanoparticles enhance the antimicrobial activity of the phosphoinositide-binding domain of gelsolin, modulate its mode of action and strengthen the idea of its employment for developing the new treatment methods of infections.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsBiofilmsCandidaCell MembraneGelsolinGoldMagnetite NanoparticlesMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsNanoshellsPeptide FragmentsPlanktonPseudomonas aeruginosaRhodaminesAnti-Bacterial AgentsAntifungal AgentsGelsolingelsolin (160-169)GoldMagnetite NanoparticlesPeptide Fragmentsrhodamine BRhodaminesAntibacterialFungal cellsGelsolinMagnetic nanoparticlesPBP10 peptide

Identifiers

PMID31286976
PMCPMC6615188
OpenAlexW2961756413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.